Orange Book product · Brand (NDA)
DESMODA
DESMOPRESSIN ACETATE
At a glance
Feb 25, 2026
Approved
Brand (NDA)
Application
Not listed
TE code
2
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Feb 25, 2026
4 mo ago
Today
Patent 12214010 expires
Listed drug product patent expiration.
Apr 03, 2044
in 18 yr 1 mo
Patent 12343372 expires
Listed drug product patent expiration.
Apr 03, 2044
in 18 yr 1 mo
Pharmaceutical detail
Active ingredient
DESMOPRESSIN ACETATE
Strength
0.05MG/ML
Dosage form
SOLUTION
Route
ORAL
TE code
Not listed
Application
NDA 219873
Product number
001
Marketing status
RX
Reference listed drug (RLD)
Yes
Reference standard (RS)
Yes
Active-ingredient family
View full familyThis is a reference-listed drug (RLD) — the basis for generic (ANDA) applications. Other products sharing this ingredient are listed below.
- 2018NOCDURNABrand (NDA)
NDA 022517 · FERRING PHARMS INC
- 2017NOCTIVABrand (NDA)
NDA 201656 · ACERUS PHARMS
- 2008DESMOPRESSIN ACETATEBrand (NDA)
NDA 021795 · FERRING
- 2002MINIRINBrand (NDA)
NDA 021333 · FERRING
- 1995DDAVPBrand (NDA)
NDA 019955 · FERRING PHARMS INC
- 1994STIMATEBrand (NDA)
NDA 020355 · FERRING PHARMS INC
- 1990CONCENTRAIDBrand (NDA)
NDA 019776 · FERRING
- 1984DDAVPBrand (NDA)
NDA 018938 · NORDIC PHARMA
- —DDAVPBrand (NDA)
NDA 017922 · FERRING PHARMS INC
- 2026DESMOPRESSIN ACETATEGeneric (ANDA)
ANDA 219981 · CAPLIN
- 2024DESMOPRESSIN ACETATEGeneric (ANDA)
ANDA 213095 · AUROBINDO PHARMA
- 2023DESMOPRESSIN ACETATEGeneric (ANDA)
ANDA 216904 · GLAND
Listed patents (2)
| Patent | Expires | In | Type |
|---|---|---|---|
| 12214010 | Apr 03, 2044 | in 18 yr 1 mo | Product |
| 12343372 | Apr 03, 2044 | in 18 yr 1 mo | ProductU-4432 |

